Transformation to Lung Adenocarcinoma From Complete Remission-Experienced SCLC

被引：2
|
作者：
Wang, Zhongyu [1 ]
Jia, Qingzhu [1 ]
Tang, Xuefeng [2 ]
Yan, Lvjun [1 ]
Zhu, Bo [1 ]
机构：
[1] Third Mil Med Univ, Xinqiao Hosp, Inst Canc, 183 Xinqiao Main St, Chongqing 400037, Peoples R China
[2] Third Mil Med Univ, Xinqiao Hosp, Dept Pathol, Chongqing, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2020年 / 15卷 / 01期
基金：
中国国家自然科学基金;
关键词：
CANCER;
D O I：
10.1016/j.jtho.2019.07.035
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E1 / E3
页数：3
相关论文
共 50 条
  • [31] Clinical and genetic characteristics of EGFR-mutant lung adenocarcinoma transformed SCLC.
    Gu, Linping
    Zhang, Bei
    Zhang, Ding
    Jian, Hong
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [32] ALK-Positive Adenocarcinoma After Acquired Resistance to Lorlatinib and Transformation to SCLC: A Case Report
    Li, Huihui
    Song, Tianqi
    Xu, Xiaoling
    JTO CLINICAL AND RESEARCH REPORTS, 2023, 4 (02):
  • [33] Recurrence of Pancreatic Ductal Adenocarcinoma after Complete Histopathological Remission Caused by FOLFIRINOX
    Hoehn, Philipp
    Braumann, Chris
    Noepel-Duennebacke, Stefanie
    Munding, Johanna
    Uhl, Waldemar
    Luu, Andreas Minh
    VISCERAL MEDICINE, 2021, 37 (02) : 149 - 153
  • [34] Clinicopathological features of patients with transformation from EGFR mutant lung adenocarcinoma to small cell lung cancer
    Bai, Wenwen
    Zhen, Chanjun
    Zhang, Ruohui
    Yu, Wenhui
    Zhou, Zhiguo
    TRANSLATIONAL CANCER RESEARCH, 2021, 10 (08) : 3694 - 3704
  • [35] COMPLETE REMISSION OF HORMONE-REFRACTORY ADENOCARCINOMA OF THE PROSTATE IN RESPONSE TO WITHDRAWAL OF DIETHYLSTILBESTROL
    BISSADA, NK
    KACZMAREK, AT
    JOURNAL OF UROLOGY, 1995, 153 (06): : 1944 - 1945
  • [36] Complete Metabolic Response in Adenocarcinoma Lung With Lymphangitic Carcinomatosis
    Goyal, Harish
    Kishore, Sai
    Ganesan, Prasanth
    Halanaik, Dhanapathi
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (03) : E133 - E134
  • [37] Complete workflow for Discovery and Verification of eQTLs in Lung Adenocarcinoma
    Veereshlingam, H.
    Jackson, S.
    Tommaso, D.
    Colombo, F.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1698 - 1698
  • [38] Durable complete remission of poor performance status metastatic lung adenocarcinoma patient treated with second-line erlotinib: a case report
    Jovanovic, Dragana
    Stevic, Ruza
    Velinovic, Marta
    Kontic, Milica
    Maric, Dragana
    Spasic, Jelena
    Radosavljevic, Davorin
    ONCOTARGETS AND THERAPY, 2017, 10 : 4347 - 4354
  • [39] Anesthetic Management for Lung Adenocarcinoma Experienced Acute Neurocardiogenic Syncope and Cardiac Arrest
    Han, Jin Hye
    Kim, Youn Jin
    Kim, Jong Hak
    Kim, Dong Yeon
    Lee, Guie Yong
    Kim, Chi Hyo
    EWHA MEDICAL JOURNAL, 2014, 37 : 28 - 32
  • [40] OsimertinibOsimertinib resistance and transformation from adenocarcinoma to small cell lung cancer: case report
    Reactions Weekly, 2020, 1791 (1) : 203 - 203
12345